• 제목/요약/키워드: Cas9 activity

검색결과 34건 처리시간 0.024초

Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis

  • Liu, Shuai;Yu, Xiao;Wang, Qiankun;Liu, Zhepeng;Xiao, Qiaoqiao;Hou, Panpan;Hu, Ying;Hou, Wei;Yang, Zhanqiu;Guo, Deyin;Chen, Shuliang
    • Journal of Microbiology and Biotechnology
    • /
    • 제27권10호
    • /
    • pp.1855-1866
    • /
    • 2017
  • The synergistic activation mediator (SAM) system can robustly activate endogenous gene expression by a single-guide RNA. This transcriptional modulation has been shown to enhance gene promoter activity and leads to epigenetic changes. Human $interferon-{\gamma}$ is a common natural glycoprotein involved in antiviral effects and inhibition of cancer cell growth. Large quantities of high-purity $interferon-{\gamma}$ are important for medical research and clinical therapy. To investigate the possibility of employing the SAM system to enhance endogenous human $interferon-{\gamma}$ with normal function in innate immunity, we designed 10 single-guide RNAs that target 200 bp upstream of the transcription start sites of the $interferon-{\gamma}$ genome, which could significantly activate the $interferon-{\gamma}$ promoter reporter. We confirmed that the system can effectively and highly activate $interferon-{\gamma}$ expression in several humanized cell lines. Moreover, we found that the $interferon-{\gamma}$ induced by the SAM system could inhibit tumorigenesis. Taken together, our results reveal that the SAM system can modulate epigenetic traits of non-immune cells through activating $interferon-{\gamma}$ expression and triggering JAK-STAT signaling pathways. Thus, this strategy could offer a novel approach to inhibit tumorigenesis without using exogenous $interferon-{\gamma}$.

Enhanced Production of Soluble Pyrococcus furiosus α-Amylase in Bacillus subtilis through Chaperone Co-Expression, Heat Treatment and Fermentation Optimization

  • Zhang, Kang;Tan, Ruiting;Yao, Dongbang;Su, Lingqia;Xia, Yongmei;Wu, Jing
    • Journal of Microbiology and Biotechnology
    • /
    • 제31권4호
    • /
    • pp.570-583
    • /
    • 2021
  • Pyrococcus furiosus α-amylase can hydrolyze α-1,4 linkages in starch and related carbohydrates under hyperthermophilic condition (~ 100℃), showing great potential in a wide range of industrial applications, while its relatively low productivity from heterologous hosts has limited the industrial applications. Bacillus subtilis, a gram-positive bacterium, has been widely used in industrial production for its non-pathogenic and powerful secretory characteristics. This study was conducted to increase production of P. furiosus α-amylase in B. subtilis through three strategies. Initial experiments showed that co-expression of P. furiosus molecular chaperone peptidyl-prolyl cis-trans isomerase through genomic integration mode, using a CRISPR/Cas9 system, increased soluble amylase production. Therefore, considering that native P. furiosus α-amylase is produced within a hyperthermophilic environment and is highly thermostable, heat treatment of intact culture at 90℃ for 15 min was performed, thereby greatly increasing soluble amylase production. After optimization of the culture conditions (nitrogen source, carbon source, metal ion, temperature and pH), experiments in a 3-L fermenter yielded a soluble activity of 3,806.7 U/ml, which was 3.3- and 28.2-fold those of a control without heat treatment (1,155.1 U/ml) and an empty expression vector control (135.1 U/ml), respectively. This represents the highest P. furiosus α-amylase production reported to date and should promote innovation in the starch liquefaction process and related industrial productions. Meanwhile, heat treatment, which may promote folding of aggregated P. furiosus α-amylase into a soluble, active form through the transfer of kinetic energy, may be of general benefit when producing proteins from thermophilic archaea.

Auxin과 ACC Deaminase를 생산하는 사구식물 복원용 근권세균의 선발 (Selection of the Auxin and ACC Deaminase Producing Plant Growth Promoting Rhizobacteria from the Coastal Sand Dune Plants)

  • 임종희;김종국;김상달
    • 한국미생물·생명공학회지
    • /
    • 제36권4호
    • /
    • pp.268-275
    • /
    • 2008
  • 경북포항지역의 해안사구지역에서 서식하는 11종의 해안사구 식물의 근권으로부터 1,330균주의 근권세균들을 분리하였다. 이들 분리된 근권세균등 중에서 9종의 주요 식물병원성 진균인 Phytophthora capsici, Fusarium oxysporum, Corynespora casriicola, Colletotrichum acutatum, Botrytis cinerea, Rhizoctonia solani AG-1(IA), Pythium ultimum, Rhizoctonia solani AG-1(IB)에 대하여 넓은 항진균성 스펙트럼을 가지고 동시에 생장촉진호로몬 옥신을 생산하는 23균주의 근권세균을 선발하였다. 1차 선발된 23균주의 옥신 생산성 사구식물근권세균들에서 19균주가 항진균성 siderophore를, 4균주가 항진균성 cellulase를 생산할 수 있었으며, 17균주는 불용성 인산염을 분해할 수 있었다. 또, 23균주의 선발된 사구식물생장 촉진 근권세균들은 16S rDNA 염기서열 조사와 Bergey's manual에 의하여 99%이상의 상동성을가지는 7균주의 Bacillus sp.균주들과 15균주 Pseudomonas sp.균주들로 동정할 수 있었다. 한편, 이들 중 다기능 사구식물생장촉진 근권세균인 Pseudomonas fluorescens IB4-14는 고염, 건조와 같은 환경스트레스에 저항성을 가질 수 있게 하는 ACC deaminase를 생산하므로써 식물생장촉진은 물론이고, 환경스트레스 저항성 기작을 가지는 다중기능 균주이었다. 또한, 선발된 옥신생산성 다기능 균주인 P. fluorescens IB4-14는 사구식물인 갯까치수영의 종자발아능과 뿌리생장촉진능에서 우수한 생육촉진능을 발휘함을 확인하였으므로 사구식물 복원에 사용할 미생물제제의 구성균주로 선발되었다고 생각한다.

신규 항암성 화합물 아크리플라빈과 구아노신 복합체를 흰쥐에 근육주사시 아크리플라빈의 체내분포 (Distribution of Acriflavine in Rats Following Intramuscular Administration of a Mixture of Acriflavine and Guanosine, a Potential Antitumor Agent)

  • 송석길;정연복
    • 약학회지
    • /
    • 제50권1호
    • /
    • pp.8-14
    • /
    • 2006
  • A 1 : 1 mixture of acriflavine (ACF; CAS 8063-24-9) and guanosine is currently being evaluated as a possible antitumor agent in preclinical studies. Guanosine is known to potentiate the anticancer activity of some compounds. However, the distributions of trypaflavine (TRF) or proflavine (PRF) have not been investigated in mammals. We, therefore, investigated the distribution of TRF and PRF after i.m. administration of the combination mixture (ACF and guanosine) at a dose of 30 mg/kg ACF in rats. to analyze TRF and PRF levels in biological samples, we used an HPLC-based method. The calibration curves for TRF and PRF in the samples were linear over the concenration range of $0.05{\sim}200\;{\mu}g/ml$. The intra- and inter-day assay accuracies of this method were within ${\pm}15\%$ of norminal values and the precision did not exceed $15\%$ of relative standard diviation. The lower limits of quantitation were 50 ng/ml for both TRF and PRF. The distribution of TRF or PRF was determined by 48 h after i.m. administration of the combination mixture at a dose of 30 mg/kg ACF. TRF and PRF were distributed as the following order; kidney>lung>liver>small intestine>muscle. Of the various tissues, TRF and PRF were mainly distributed to the kidney and lung. The concentrations of TRF or PRF in the tissues 24 h after i.m. administration decreased to undetectable levels. The concentrations of TRF or PRF in the blood cells were comparable to those for the plasma. However, the concentrations of TRF or PRF in the both plasma and blood cells 12 h after i.m. administration were not detected. The number of the platelets in the 1 ml of the blood was calculated to be $0.183{\times}10^8/ml$ of blood. The PRF concentration in platelets was higher than that of TRF at initial times after i.m. administration of the combination mixture. However, both the TRF and PRF concentrations in the plateles 24 h after i.m. administration of the combination mixture were below the quantifiable limit. In conclusion, the concentrations of TRF or PRF in the various tissues, plasma, blood cells, and plateles decreased to undetectable levels 24 h after i.m. administration of the combination mixture at a dose of 30 mg/kg ACF.